* Note: Prices are in Million (M) USD.
Description:
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $10 M
Debt : $1 M
EBITDA : $13 M
Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Health Information Services
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Message: Cannot calculate PE Ratio since EPS is either 0 or negative.
Using default values for calculation.
Forward PE Ratio (using default values): 20.00
Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $6 M
Average Revenue: $25 M
Revenue Converted To Free Cash Flow (%): 24%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 11.13%
Since Free Cash Flow (FCF) to Revenue percentage is greater than 15, 3 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-08-31): $70 M
Revenue 4 Years Ago (2020-08-31): $42 M
Last 5 Years Average Revenue Growth: 14%
Since Revenue Growth is between 10 - 15, 3 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-08-31): $20 M
Share Count 5 Years Ago (2020-08-31): $19 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Message: Cannot calculate payout ratio because EPS is either 0 or negative.
Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 18%
Since Average ROE is between 10 - 20, 3 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $15
52-Week Low: $12
Threshold Price (15% Above 52-Week Low): $14
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $263 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based the market cap, we recommend do not exceed 0.5% exposure of Total Portfolio.
Value-Trade has assigned 21 points to above Simulations Plus Inc (SLP) stock.
Last 12 Years Avg PE 30.42, Fair Value PE 15, Industry Based PE 20, Growth Based PE 13, RCFC Based PE 24.2. Based on these 5 values, average assigned is 20.52.
The fair value of Simulations Plus Inc (SLP) stock cannot be calculated since EBITDA and EPS are either 0 or negative.
